Cardiovascular outcomes, heart failure and mortality in type 2 diabetic patients treated with glucagon‐like peptide 1 receptor agonists (GLP‐1 RAs): A systematic review and meta‐analysis of observational cohort studies-Reference-Cited by-同舟云学术

Cardiovascular outcomes, heart failure and mortality in type 2 diabetic patients treated with glucagon‐like peptide 1 receptor agonists (GLP‐1 RAs): A systematic review and meta‐analysis of observational cohort studies

Published:2020-06-17 Issue:9 Volume:74 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Herrera Comoglio Raquel¹²^ORCID,Vidal Guitart Xavier²³^ORCID

Affiliation:

1. School of Medicine Universidad Nacional de Córdoba Córdoba Argentina

2. Eu2P European Programme in Pharmacovigilance and Pharmacoepidemiology University of Bordeaux Segalen Bordeaux France

3. Fundacio Institut Catala de Farmacologia Universitat Autonoma de Barcelona Barcelona Spain

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.13553

Reference57 articles.

1. Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; The National Heart, Lung and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association;Circulation,1999

2. Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus

3. Diabetes Mellitus and Heart Failure

4. Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy

5. Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative safety and cardiovascular effectiveness of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists in nursing homes;Diabetes, Obesity and Metabolism;2024-05-23

2. The Impact of Glucagon-Like Peptide-1 Receptor Agonist on the Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis and Systematic Review;Cardiology Research;2023-08

3. Review of the correlation between Chinese medicine and intestinal microbiota on the efficacy of diabetes mellitus;Frontiers in Endocrinology;2023-01-25

4. New Antidiabetic Agents for the Treatment of Heart Failure in Hypertensive Patients;Updates in Hypertension and Cardiovascular Protection;2023

5. Insulin–glucagon‐like peptide‐1 receptor agonist relay and glucagon‐like peptide‐1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open‐label trial study;Journal of Diabetes Investigation;2022-02-08